Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

http://www.wikidata.org/entity/Q40477472

about

International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective Melatonin in Alzheimer's disease and other neurodegenerative disorders Melatonin facilitates extinction, but not acquisition or expression, of conditional cued fear in rats.The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors.Endogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle.Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.Melatonin and anesthesia: a clinical perspective.Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model.Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.Potency of melatonin in living beings The MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling.Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers.The pattern of melatonin receptor expression in the brain may influence antidepressant treatment Melatonin Therapy in Patients with Alzheimer's Disease.Role of melatonin in Alzheimer-like neurodegeneration.Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease.Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors.Therapeutic application of melatonin in mild cognitive impairment.Gene and protein patterns of potential prion-related markers in the central nervous system of clinical and preclinical infected sheep Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?Melatonin in Alzheimer's disease Melatonin, consciousness, and traumatic stress.Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence.Developmental effect of light deprivation on synaptic plasticity of rats' hippocampus: implications for melatonin.Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.Chronic ramelteon treatment in a mouse model of Alzheimer's disease.The end of a myth: cloning and characterization of the ovine melatonin MT(2) receptor.Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists.The hormonal Zeitgeber melatonin: role as a circadian modulator in memory processing.Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.Protection of melatonin in experimental models of newborn hypoxic-ischemic brain injury through MT1 receptor.Monoaminergic neuropathology in Alzheimer's disease.Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.Mechanisms of Melatonin in Alleviating Alzheimer's Disease.Melatonin receptors: distribution in mammalian brain and their respective putative functions.

P2860

Q24623433-853A8F3B-25E7-485D-AB35-41271F829CC1 Q28075345-439881F1-C0D9-41EA-9C82-34A4E5DF85EC Q28083929-F92FE178-3BB8-4BB6-9C97-86368A3FBF1D Q28217483-03B15437-97FB-4C7C-ABD1-8C9572C010DE Q30434239-894403FC-D223-4468-AA9D-EC6E897E8204 Q33823742-E5F52AA6-7662-46CF-81AC-1853104211EE Q33897576-20E16F04-7470-4FB4-9EF5-601B45341B37 Q34416921-018EEE5A-9D06-4093-B4BB-19A51ED29BE2 Q34596664-B1CECF41-46B8-4A77-8F6F-1CDCBB753460 Q34633689-06513DB6-5314-43EE-A359-F0858043FCD7 Q34640994-0348EC36-D7A6-47AC-BB21-FDB1A01FE3BF Q34804952-AB3A601B-378F-4AC1-929D-3EA7A92728D3 Q35167615-3EC108A6-C347-4318-960A-9F4F505AFF13 Q35561050-F2E0FAEF-83B6-4DD5-9088-D45EC0829C66 Q35945875-22C692E5-4B4B-42BD-90D9-E788AAF79003 Q36335048-3C59DA22-AE07-40B7-B3E4-FC59003F04DA Q36346522-8787B1AF-4857-48D5-ABCF-E0ACC44BEF01 Q36423565-C892A8AE-1B06-4EC0-91BA-B94CC21EE4C4 Q36473222-A264E996-4002-4C27-B753-894D79102745 Q36474528-C700D2B5-8B52-4365-A70D-607D6A047CB0 Q36576496-C037B49E-DB54-461B-AB2F-9C7519C85E3B Q36716041-7154D767-2E68-4B83-A18F-444BD7498383 Q36790172-7AB7046E-69B2-4DBA-8769-22F3AF72AFD0 Q37091982-01EAA2B7-9DF7-46F0-8B03-673A3D2DFC36 Q37138014-CF71812F-1F2A-4252-9E40-33471879FDB9 Q37253704-9B26571E-AB29-4E1A-A434-EAC62E00FEEB Q37306951-546AA910-F5CD-4E25-95BC-43A4F42FF509 Q37404821-1456B0CD-CFE2-43D7-A402-5A2539A56EF3 Q37412437-4521E050-E7BB-4850-B7BD-30CA67C4545A Q37434418-9FB7BDDF-DD3A-459E-8DA9-D67821C725B4 Q37612356-895DDF99-D4C8-466A-B390-1D5E96A20294 Q37763715-9F4797BB-F924-426E-9063-C65DC8954239 Q37992626-4176FEA7-39DF-4A7A-95D2-ADBB6A68561F Q38022179-1FE0015C-23E4-4DBC-8AF6-81C046D33A7A Q38243554-07DF9B14-9C32-4288-A41F-C0236E8063F2 Q38630639-A2611398-F8A0-4FDC-BE70-410627BA1B5F Q38809649-B3AC18BA-88A6-411F-9097-145FC3BB93DE Q38858846-E95A8A19-CD37-47C6-8472-EB23FA047EF4 Q39178920-BD563B57-6658-4F47-B74C-7938B63300A6 Q39288514-00610903-196B-4C97-B5E0-7903F75DB662

P2860

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

http://www.wikidata.org/entity/Q40477472

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

@en

type

label

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

@en

prefLabel

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

@en

P1433

Q40477472-29CA381C-BD8C-4F30-A076-F18E523CCE68

P1476

Q40477472-8D0CBDC6-5FD5-4A99-B0C8-64BFB0599CF9

P2093

Q40477472-030C85F2-BDDD-40EB-8449-8B6ADD9B3F0B

Q40477472-4CBFFCE6-77B4-40E0-A4B5-F2529A679E2A

Q40477472-8653C9BB-071D-4A88-8486-169A35FD91C2

Q40477472-B2337642-0C1D-4408-B912-EE6E38CB69FD

Q40477472-C118D78F-3FAC-4ADF-A47E-AC183941BF08

Q40477472-F276F13D-3BB8-41F0-9C41-6B80BDD20287

Q40477472-F35FB4A2-804A-490A-8AC8-5F8E6AEE3F3E

P2860

Q40477472-0D1FC314-15C9-4CAB-B8AB-74BC875B240A

Q40477472-20E9B23E-077C-48E1-A911-B803BE7F816A

Q40477472-2A27A57D-D9F4-4056-A6DC-831AD8610A6F

Q40477472-31023BAD-F1F1-4321-B474-00F4B5E8C417

Q40477472-36D244C9-D7E1-45D3-82A3-854953D7AC4E

Q40477472-37A739B6-3058-4A1D-BBFF-C5838F5B59E4

Q40477472-3DE60EF5-D3BE-457D-8A4D-A6328C4DBCB7

Q40477472-4EDC55FD-2F68-4F30-97A2-94FDB642C652

Q40477472-5CC1236D-C1AF-4F28-AF5F-EEC5441F9122

Q40477472-7B112B8D-39C4-49FC-9E41-990540060140

P304

Q40477472-3FEF721C-B343-4F3A-88B8-9659B3B5CE01

P31

Q40477472-DB124CA7-47D8-429D-A4FE-A41C537AFA46

P356

Q40477472-DCB38C85-49AB-43F7-87D2-188E45832CBC

P433

Q40477472-CEE6D036-18E7-4F79-9FE5-60F9F562A16C

P478

Q40477472-1C6363A8-28E0-484C-9B5F-465599CEB410

P50

Q40477472-3EE641F9-0153-4FF6-9EC0-8809361A021B

Q40477472-939C765C-5D74-4535-8E0E-1070B41D93C5

P577

Q40477472-39FD967B-A3B2-48EF-B116-869FDB1D0CDA

P698

Q40477472-F45C7897-ED67-4D4D-BC81-6135BE0F8284

P921

Q40477472-759C21A6-A942-4A31-B8C8-076748DC70B5

Q40477472-C4632CA7-3213-4607-9AD2-2E5C8724CACF

P356

J.1600-079X.2004.00169.X

P1433

Journal of Pineal Research

P1476

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.

@en

P2093

Debora Angeloni

http://www.w3.org/2001/XMLSchema#string

Egemen Savaskan

http://www.w3.org/2001/XMLSchema#string

Fides Meier

http://www.w3.org/2001/XMLSchema#string

Franco Fraschini

http://www.w3.org/2001/XMLSchema#string

Franz Müller-Spahn

http://www.w3.org/2001/XMLSchema#string

Ralf Jockers

http://www.w3.org/2001/XMLSchema#string

Rivka Ravid

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins

Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients

Distribution of melatonin MT1 receptor immunoreactivity in human retina

Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer

Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles.

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease.

Mammalian melatonin receptors: molecular biology and signal transduction.

P304

10-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-079X.2004.00169.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Mohammed A Ayoub

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15617532

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease